Several studies have shown that a sub-fraction of breast cancer cells termed BTICs undergo EMT reprogramming and typically exhibit a basal-like CD44+/CD24- phenotype harboring cancer stem-like features [43-45]. This evidence concerns the gene CD24 and cancer.